Fellowship · Mineola, NY
Sponsored by NYU Grossman Long Island School of Medicine
Combination Therapies Including Cilofexor and Firsocostat for Bridging Fibrosis and Cirrhosis Attributable to NASH.
Hepatology (Baltimore, Md.) · 2021 · 250 citations · Bal Bhandari
Safety and efficacy of remimazolam in high risk colonoscopy: A randomized trial.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver · 2021 · 122 citations · Bal Bhandari
A randomized phase 3 trial of interferon-α vs hydroxyurea in polycythemia vera and essential thrombocythemia.
Blood · 2022 · 122 citations · Joseph Tripodi
Peroral endoscopic myotomy: 10-year outcomes from a large, single-center U.S. series with high follow-up completion and comprehensive analysis of long-term efficacy, safety, objective GERD, and endoscopic functional luminal assessment.
Gastrointestinal endoscopy · 2021 · 76 citations · Rani Modayil, Bhawna Halwan
Endoscopic papillectomy versus surgical ampullectomy for adenomas and early cancers of the papilla: a retrospective Pancreas2000/European Pancreatic Club analysis.
Gut · 2025 · 19 citations · Galen Leung
Digital single-operator cholangioscopy interobserver study using a new classification: the Mendoza Classification (with video).
Gastrointestinal endoscopy · 2022 · 48 citations · Jessica Widmer
Fenofibrate Mitigates Hypertriglyceridemia in Nonalcoholic Steatohepatitis Patients Treated With Cilofexor/Firsocostat.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2023 · 42 citations · Bal Bhandari
Complement activation in tumor microenvironment after neoadjuvant therapy and its impact on pancreatic cancer outcomes.
NPJ precision oncology · 2025 · 15 citations · Jessica Widmer